Clinical Trial Update: Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating celecoxib for relapsed prostate cancer after radiation therapy or radical prostatectomy, with the study status reported as t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED